InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001477449-23-000036 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-09-06 2023-09-01 TDOC Geshuri Arnnon CHRO M - OptEx — +1,179 76.8K +2% —
D 2023-09-06 2023-09-05 TDOC Geshuri Arnnon CHRO S - Sale+OE $22.89 -408 76.4K -0.5% -$9,339
D 2023-09-06 2023-09-01 TDOC Geshuri Arnnon CHRO M - OptEx $0.00 -1,179 7,075 -14% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-09-01 M A 1,179 — 76,809 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2023-09-05 S D 408 $22.89 76,401 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2023-09-01 M D 1,179 $0.00 7,075 D — · — to — 1,179 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.